"Unfortunately it puts the viability of all health research in Newfoundland and Labrador at question," said Sequence Bio CEO and president Chris Gardner. Chris Gardner is president and CEO of St. John's-based Sequence Bio. The latest rejection from the ethics authority came shortly after the company filed a court application seeking a ruling that the ethics authority must make decisions within 30 days of receiving applications. "We do and we view keeping this court action alive as a way to highlight all the systemic issues with the Health Research Ethics Board and hope to enact change." In an email to CBC News, the Health Research Ethics Authority for Newfoundland and Labrador said is not able to comment on matters that are before the courts.

Source: CBC News May 04, 2018 10:30 UTC